Difference between revisions of "Chiron Vaccines"
(page created, basic company info added, SMC funding added) |
m (→Contact) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
From the OBN website: | From the OBN website: | ||
| − | :Chiron Vaccines is the world's fifth largest vaccines company and has its headquarters in Oxford, UK, with facilities located throughout Europe, the US and Asia. The company is the world's second largest manufacturer of flu vaccines, and has important meningitis, paediatric and travel vaccine franchises. Chiron Vaccines is the leading vaccine manufacturer in the UK, Germany and Italy, and its portfolio of products includes vaccines for influenza, meningitis C, yellow fever, rabies, tick borne encephalitis, haemophilus influenzae B (Hib), polio, mumps, measles and rubella (MMR) and diphtheria, tetanus and pertussis (whooping cough).<ref>[http://www.obn.org.uk/obn_/menu.php?p=org_.tem&r=r8ehxjd5ad Chiron Vaccines], OBN.</ref> | + | :Chiron Vaccines is the world's fifth largest vaccines company and has its headquarters in Oxford, UK, with facilities located throughout Europe, the US and Asia. The company is the world's second largest manufacturer of flu vaccines, and has important meningitis, paediatric and travel vaccine franchises. Chiron Vaccines is the leading vaccine manufacturer in the UK, Germany and Italy, and its portfolio of products includes vaccines for influenza, meningitis C, yellow fever, rabies, tick borne encephalitis, haemophilus influenzae B (Hib), polio, mumps, measles and rubella (MMR) and diphtheria, tetanus and pertussis (whooping cough).<ref>[http://www.obn.org.uk/obn_/menu.php?p=org_.tem&r=r8ehxjd5ad Chiron Vaccines], OBN website. Accessed on 23/10/13.</ref> |
| + | |||
| + | Chiron Corporation was acquired by [[Novartis|Novartis International AG]] on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines and blood testing.<ref>[https://www.linkedin.com/company/chiron-corporation 'Chiron Corporation profile'], ''LinkedIn''.</ref> | ||
| + | |||
| + | ==People== | ||
| + | ===Chiron Corporation Board of Directors 2006=== | ||
| + | *[[Howard Pien]] - Chief Executive Officer and Chairman of the Board, [[Chiron Corporation]] | ||
| + | *[[Raymund Breu]], Ph.D. - Chief Financial Officer, Member of the Executive Committee, [[Novartis]] AG | ||
| + | *[[Vaughn D. Bryson]] - Retired President and Chief Executive Officer, [[Eli Lilly]] and Company | ||
| + | *[[Lewis W. Coleman]] - Retired | ||
| + | *[[Pierre E. Douaze]] - Board Member, Serono S.A. Board Member, [[Galenica Group]] | ||
| + | *[[J. Richard Fredericks]] - Chairman, [[Dionis Capital]]. Former U.S. Ambassador to Switzerland and Liechtenstein | ||
| + | *[[Paul L. Herrling]], Ph.D. - Head of Corporate Research, [[Novartis]] International AG | ||
| + | *[[Denise O'Leary]] - Private Venture Capital Investor | ||
| + | *[[Edward E. Penhoet]], Ph.D. - President, [[Gordon and Betty Moore Foundation]]. | ||
| + | *[[Pieter J. Strijkert]], Ph.D. - Chairman of the Board, Crucell N.V.<ref>[https://web.archive.org/web/20060215172605/http://www.chiron.com/aboutus/board/index.html Board of Directors], Chiron Corporation, accessed via the Internet archive of 15 February 2006 on 12 july 2016.</ref> | ||
==Contact== | ==Contact== | ||
| Line 8: | Line 23: | ||
:email:info@chironvaccines.com | :email:info@chironvaccines.com | ||
:fax: 01865 332601 | :fax: 01865 332601 | ||
| − | + | :http://www.chiron.com | |
| − | :http://www.chiron.com | ||
==Affiliations== | ==Affiliations== | ||
| − | Chiron Vaccines was a donor to the [[Science Media Centre]] from | + | Chiron Vaccines was a donor to the [[Science Media Centre]] from October 2004 to February 2007 according to the SMC.<ref>Data from Internet Archive holdings of the Science Media Centre website, 2002-2013. |
*Oct 2004 http://web.archive.org/web/20041205182639/http://www.sciencemediacentre.org/funding.htm and http://web.archive.org/web/20051029205959/http://www.sciencemediacentre.org/funding.htm | *Oct 2004 http://web.archive.org/web/20041205182639/http://www.sciencemediacentre.org/funding.htm and http://web.archive.org/web/20051029205959/http://www.sciencemediacentre.org/funding.htm | ||
*Nov 2005 http://web.archive.org/web/20051227000834/http://www.sciencemediacentre.org/funding.htm | *Nov 2005 http://web.archive.org/web/20051227000834/http://www.sciencemediacentre.org/funding.htm | ||
Latest revision as of 13:46, 12 July 2016
Contents
Background
From the OBN website:
- Chiron Vaccines is the world's fifth largest vaccines company and has its headquarters in Oxford, UK, with facilities located throughout Europe, the US and Asia. The company is the world's second largest manufacturer of flu vaccines, and has important meningitis, paediatric and travel vaccine franchises. Chiron Vaccines is the leading vaccine manufacturer in the UK, Germany and Italy, and its portfolio of products includes vaccines for influenza, meningitis C, yellow fever, rabies, tick borne encephalitis, haemophilus influenzae B (Hib), polio, mumps, measles and rubella (MMR) and diphtheria, tetanus and pertussis (whooping cough).[1]
Chiron Corporation was acquired by Novartis International AG on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines and blood testing.[2]
People
Chiron Corporation Board of Directors 2006
- Howard Pien - Chief Executive Officer and Chairman of the Board, Chiron Corporation
- Raymund Breu, Ph.D. - Chief Financial Officer, Member of the Executive Committee, Novartis AG
- Vaughn D. Bryson - Retired President and Chief Executive Officer, Eli Lilly and Company
- Lewis W. Coleman - Retired
- Pierre E. Douaze - Board Member, Serono S.A. Board Member, Galenica Group
- J. Richard Fredericks - Chairman, Dionis Capital. Former U.S. Ambassador to Switzerland and Liechtenstein
- Paul L. Herrling, Ph.D. - Head of Corporate Research, Novartis International AG
- Denise O'Leary - Private Venture Capital Investor
- Edward E. Penhoet, Ph.D. - President, Gordon and Betty Moore Foundation.
- Pieter J. Strijkert, Ph.D. - Chairman of the Board, Crucell N.V.[3]
Contact
- Phone:01865 782800
- email:info@chironvaccines.com
- fax: 01865 332601
- http://www.chiron.com
Affiliations
Chiron Vaccines was a donor to the Science Media Centre from October 2004 to February 2007 according to the SMC.[4]
References
- ↑ Chiron Vaccines, OBN website. Accessed on 23/10/13.
- ↑ 'Chiron Corporation profile', LinkedIn.
- ↑ Board of Directors, Chiron Corporation, accessed via the Internet archive of 15 February 2006 on 12 july 2016.
- ↑ Data from Internet Archive holdings of the Science Media Centre website, 2002-2013.
- Oct 2004 http://web.archive.org/web/20041205182639/http://www.sciencemediacentre.org/funding.htm and http://web.archive.org/web/20051029205959/http://www.sciencemediacentre.org/funding.htm
- Nov 2005 http://web.archive.org/web/20051227000834/http://www.sciencemediacentre.org/funding.htm
- Apr 2006 http://web.archive.org/web/20060910221525/http://www.sciencemediacentre.org/funding.htm
- Feb 2007 http://web.archive.org/web/20070829210611/http://www.sciencemediacentre.org/funding.htm
